Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The extensive SUSTAIN and STEP clinical trial programmes, which evaluated semaglutide's safety and efficacy, have not shown a signal for increased incidence of gastrointestinal bleeding compared to placebo or active comparators, as documented in the European Medicines Agency's European Public Assessment Report (EPAR)
Discuss the cause
Serious side effects are rare but include pancreatitis signs (severe abdominal pain) and hypoglycemia if you're also on diabetes medications
Eur.J Clin.Nutr
US$ 26.99
US$ 27.52
US$ 24.27
US$ 25.10
US$ 28.73
US$ 21.79
US$ 25.05
